Short-term survival in breast cancer: The experience of the University of Malaya Medical Centre

Asian Journal of Surgery

Volumn 26, Issue 3, 2003, Pages 169-175

  Ong, Teng Aik ^a   Yip, Cheng Har ^b  

^a UNIVERSITI MALAYSIA SARAWAK   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; ANALYTIC METHOD; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ETHNIC GROUP; EVALUATION; EXPERIENCE; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALAYSIA; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PROGNOSIS; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME; UNIVERSITY HOSPITAL;

EID: 0042018777     PISSN: 10159584     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1015-9584(09)60378-X     Document Type: Article

References (34)

1. Edge SB, Levine EG, Arredondo MA, Tezcan H. Breast carcinoma. In: Johnson FE, Virgo KS, eds. Cancer Patient Follow-Up. St Louis: Mosby, 1997:290-335.
2. Langlands AO. Prognostic factors and the curability of breast cancer. Aust N Z J Surg 1995;65:630-3.
3. Rosen PR, Groshen S, Saigo PE, et al. A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol 1989;7:355-66.
4. Richert-Boe KE. Heterogeneity of cancer surveillance practices among medical oncologists in Washington and Oregon. Cancer 1995;75:2605-12.
5. Saez RA, McGuire WL, Clark GM. Prognostic factors in breast cancer. Semin Surg Oncol 1989;5:102-10.
6. Lipponen P, Aaltomaa S, Eskelinen M, et al. The changing importance of prognostic factors in breast cancer during long-term follow-up. Int J Cancer 1992;51:698-702.
7. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63:181-7.
8. Jatoi I, Hilsenbeck SG, Clark GM, Osborne CK. Significance of axillary lymph node metastasis in primary breast cancer. J Clin Oncol 1999;17:2334-40.
9. Fisher B, Bauer M, Wickerham DL, et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer 1983;52:1551-7.
10. Tsuchiya A, Kanno M, Abe R. The impact of lymph node metastases on the survival of breast cancer patients with ten or more positive lymph nodes. Surg Today 1997;27:902-6.
11. Schmoor C, Sauerbrei W, Bastert G, et al and the German Breast Cancer Study Group. Long-term prognosis of breast cancer patients with 10 or more positive lymph nodes treated with CMF. Eur J Cancer 2001;37:1123-31.
12. Rosen PP, Groshen S, Saigo PE, et al. Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years. J Clin Oncol 1989;7:1239-51.
13. Mittra I, MacRae KD. A meta-analysis of reported correlations between prognostic factors in breast cancer: does axillary lymph node metastasis represent biology of chronology? Eur J Cancer 1991;27:1574-83.
14. Camp RL, Rimm EB, Rimm DL. A high number of tumor free axillary nodes from patients with lymph node negative breast carcinoma is associated with poor outcome. Cancer 2000;88:108-13.
15. Moorman PG, Hamza A, Marks JR, Olson JA. Prognostic significance of the number of lymph nodes examined in patients with lymph node-negative breast carcinoma. Cancer 2001;91:2258-62.
16. Knight WA, Livingston RB, Gregory EJ, McGuire WL. Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res 1977;37:4669-71.
17. Clark GM, McGuire WL. Steroid receptors and other prognostic factors in primary breast cancer. Semin Oncol 1988;15(2 Suppl 1):20-5.
18. Hawkins RA, Tesdale AL, Killen ME, et al. Prospective evaluation of prognostic factors in operable breast cancer. Br J Cancer 1996;74:1469-78.
19. Adami HO, Graffman S, Lindgren A, Sallstrom J. Prognostic implication of estrogen receptor content in bteast cancer. Breast Cancer Res Treat 1985;5:293-300.
20. nd ed. Philadelphia: Lippincott Williams & Wilkins, 2000:489-514.
21. Mason BH, Holdaway IM, Mullins PR, et al. Progesterone and estrogen receptors as prognostic variables in breast cancer. Cancer Res 1983;43:2985-90.
22. Ribeiro GG, Swindell R. The prognosis of breast carcinoma in women aged less than 40 years. Clin Radiol 1981;32:231-6.
23. Noyes RD, Spanos WJ Jr, Montague ED. Breast cancer in women aged 30 and under. Cancer 1982;49:1302-7.
24. Host H, Lund E. Age as a prognostic factor in breast cancer. Cancer 1986;57:2217-21.
25. Wallgren A, Silfversward C, Hultborn A. Carcinoma of the breast in women under 30 years of age: a clinical and histopathological study of all cases reported as carcinoma to the Swedish Cancer Registry, 1958-1968. Cancer 1977;40:916-23.
26. Hibberd AD, Horwood LJ, Wells JE. Long term prognosis of women with breast cancer in New Zealand: study of survival to 30 years. Br Med J (Clin Res Ed) 1983;286:1777-9.
27. Koscielny S, Tubiana M, Le MG, et al. Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer 1984;49:709-15.
28. Adair F, Berg J, Joubert L, Robbins GF. Long-term follow-up of breast cancer patients: the 30-year report. Cancer 1974;33:1145-50.
29. Allen DS, Bulbrook MA, Hayward JL, et al. Recurrence and survival rates in British and Japanese women with breast cancer. Breast Cancer Res Treat 1991;18(Suppl 1):S131-4.
30. Pierce L, Fowble B, Solin LJ, et al. Conservative surgery and radiation therapy in black women with early stage breast cancer. Patterns of failure and analysis of outcome. Cancer 1992;69:2831-41.
31. Elledge RM, Clark GM, Chamness GC, Osborne CK. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst 1994;86:705-12.
32. Harvey JM, de Klerk NH, Sterrett GF. Histological grading in breast cancer: interobserver agreement, and relation to other prognostic factors including ploidy. Pathology 1992;24:63-8.
33. Theissig F, Kunze KD, Haroske G, Meyer W. Histological grading of breast cancer. Interobserver, reproducibility and prognostic significance. Res Pract 1990;186:732-6.
34. Dalton LW, Page DL, Dupont WD. Histologic grading of breast carcinoma. A reproducibility study. Cancer 1994;73:2765-70.